Differential expression of α-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines

American Journal of Surgical Pathology

Volumn 29, Issue 7, 2005, Pages 890-896

  Chen, Zong Ming E ^a   Ritter, Jon H ^a   Wang, Hanlin L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

methylacyl coenzyme A racemase; Adenocarcinoma; Ampulla of vater; Colon; Microsatellite instability; Small intestine

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE;

ADENOCARCINOMA; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CARCINOMA; LARGE INTESTINE CANCER; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION; SMALL INTESTINE CANCER; STAINING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 21244443104     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000167364.90899.59     Document Type: Article

References (34)

1. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Rosai J, Sobin L, eds. Atlas of Tumor Pathology, 3rd series, fascicle 27. Washington, DC: Armed Forces Institute of Pathology; 2000:259-316.
2. Arai M, Shimizu S, Imai Y, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer. 1997;70:390-395.
3. Brueckl WM, Heinze E, Milsmann C, et al. Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett. 2004;203:181-190.
4. Chapusot C, Martin L, Puig PL, et al. What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol. 2004;28:1553-1559.
5. Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004;28:1352-1359.
6. Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996;25:722-728.
7. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403-439.
8. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769-780.
9. Delaunoit T, Neczyporenko F, Limburg PJ, et al. Pathogenesis and risk factors of small bowel adenocarcinoma: a colorectal cancer sibling? Am J Gastroenterol. 2005;100:703-710.
10. Evans AJ. α-Methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. J Clin Pathol. 2003;56:892-897.
11. Ferdinandusse S, Denis S, IJlst L, et al. Subcellular localization and physiological role of α-methylacyl-CoA racemase. J Lipid Res. 2000;41: 1890-1896.
12. Gafà R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability: pathobiologic features, hMLH1 and hMSH2 expression, and clinical outcome. Cancer. 2000;89:2025-2037.
13. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of Vater adenocarcinomas: percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001; 115:695-702.
14. Howe JR, Karnell LH, Menck HR, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999;86:2693-2706.
15. Hutchins RR, Bani Hani A, Kojodjojo P, et al. Adenocarcinoma of the small bowel. ANZ J Surg. 2001;71:428-437.
16. Jiang Z, Fanger GR, Banner BF, et al. A dietary enzyme: α-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003;27:422-426.
17. Jiang Z, Fanger GR, Woda BA, et al. Expression of α-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol. 2003;34:792-796.
18. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
19. Jiang Z, Woda BA, Wu CL, et al. Discovery and clinical application of a novel prostate cancer marker: α-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004;122:275-289.
20. Kakar S, Aksoy S, Burgart LJ, et al. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol. 2004;17:696-700.
21. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159-170.
22. Kolligs FT, Bommer G, Goke B. Wnt/beta-catenin/Tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 2002;66:131-144.
23. Luo J, Zha S, Gage WR, et al. α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002;62:2220-2226.
24. Neugut AI, Marvin MR, Relia VA, et al. An overview of adenocarcinoma of the small intestine. Oncology. 1997;11:529-536.
25. North JH, Pack MS. Malignant tumors of the small intestine: a review of 144 cases. Am Surg. 2000;66:46-51.
26. Planck M, Ericson K, Piotrowska Z, et al. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine. Cancer. 2003;97:1551-1557.
27. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology. 1997;113:127-135.
28. Rubin MA, Zhou M, Dhanasekaran SM, et al. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287: 1662-1670.
29. Sellner F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer. 1990;66:702-715.
30. Ward R, Meagher A, Tomlinson I, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48: 821-829.
31. Wheeler JM, Warren BF, Mortensen NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut. 2002;50:218-223.
32. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray Cancer Res. 2000;60:1677-1682.
33. Zhou H, Schaefer N, Wolff M, et al. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28:875-882.
34. Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.